Johnson Robert Anthony, SVP and Chief Supply Chain Officer, has executed 35 transactions in DENTSPLY SIRONA Inc. (XRAY) since March 2025, with a clear net selling bias. His total sales amount to $288,870.63, outweighing purchases of $106,123.41. The transactions primarily involve derivative holdings (code F) rather than direct open-market trades, with most recent activity concentrated in March 2026. On March 3-4, 2026, Johnson disposed of $137,789.44 in XRAY shares through three separate derivative transactions, following a $99,077.58 sale on November 28, 2025. Smaller acquisitions occurred sporadically, including $491.49 in January 2026 and multiple sub-$500 purchases in 2025, often offset by same-day dispositions of equal or zero value.
The pattern suggests Johnson has been systematically reducing his XRAY position through prearranged trading plans, with no recent purchases recorded after January 2026. The largest single transaction was the November 2025 sale, representing 34% of his total sell-side volume. Notably, all transactions involve XRAY, indicating concentrated exposure to his employer’s stock. The absence of recent buys and the acceleration of sales in early 2026—totaling $116,332.44 across five days—demonstrates a consistent divestment trend. The filings show no open-market purchases since 2025, with acquisitions limited to small, likely automated transactions under employee benefit plans.
AI-assisted summary